O. M. Lesnyak

Eprodisate for the Treatment of Renal Disease in AA Amyloidosis

Laura M. Dember, Philip N. Hawkins, Bouke P. C. Hazenberg et al. · New England Journal of Medicine · 2007 · 271 citations

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 164 citations

Bone Disease, Osteopathy, Loft Extension Study +10

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

Fredrik Borgström, Ingrid Lekander, M Ivergård et al. · Osteoporosis International · 2013 · 140 citations · Full text

Bone Disease, Quality Of Life, Osteoporotic Fractures Study +15

Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia

S A Bakhtiyarova, O. M. Lesnyak, N. Kyznesova et al. · Osteoporosis International · 2005 · 127 citations

Bone Disease, Nutrition, Skeletal Trauma +10

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS

Axel Svedbom, Fredrik Borgstöm, E Hernlund et al. · Osteoporosis International · 2017 · 125 citations

Skeletal Trauma, Lower Limb Trauma, Distal Forearm Fractures—results +5